Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.700
-0.080 (-4.49%)
Jun 26, 2025, 4:00 PM - Market closed
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $50.60 million as of June 27, 2025. Its market cap has decreased by -68.36% in one year.
Market Cap
50.60M
Enterprise Value
50.29M
1-Year Change
-68.36%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $50.60M, a decrease of -75.59%. That is a compound annual growth rate of -64.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 50.60M | -58.72% |
| Dec 31, 2024 | 122.58M | -40.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.64B |
| Johnson & Johnson | 366.49B |
| AbbVie | 327.94B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 274.09B |
| Abbott Laboratories | 239.12B |
| Novartis AG | 231.01B |
| AstraZeneca | 218.32B |